UPIIIb Activators

UPIIIb Activators are a collection of chemicals that can influence the activity or expression of the Uroplakin IIIb (UPIIIb or UPK3B) protein. This protein plays a pivotal role in the formation of the asymmetric unit membrane (AUM) in urothelial cells, which contributes to the urinary barrier function. These activators exert their effects either directly on UPIIIb or by influencing associated cellular pathways or the broader urothelial environment, thus impacting its functionality.

Epidermal Growth Factor (EGF) stimulates urothelial cell proliferation, which can directly influence UPIIIb expression as a crucial part of AUM formation. Forskolin, by activating adenylate cyclase, increases cAMP levels, which can influence urothelial differentiation and UPIIIb activity. In a similar vein, Dibutyryl-cAMP, an analog of cAMP, impacts urothelial differentiation and UPIIIb expression. A23187, known as Calcimycin, modifies intracellular calcium concentrations, affecting urothelial cell function and UPIIIb activity. Retinoic Acid plays a role in urothelial differentiation, potentially affecting UPIIIb activity during AUM formation. The compound Phorbol 12-myristate 13-acetate (PMA) serves as a PKC activator and can influence multiple cellular pathways, including those impacting urothelial differentiation and UPIIIb function. The phosphodiesterase inhibitor, 3-Isobutyl-1-methylxanthine (IBMX), elevates cAMP levels, further affecting urothelial differentiation and UPIIIb activity. Dexamethasone, a glucocorticoid, can modulate various cellular pathways in urothelial cells, influencing UPIIIb expression. Genistein, a tyrosine kinase inhibitor, U0126, a MEK inhibitor, and SB202190, a p38 MAPK inhibitor, all can modulate cellular signaling pathways in urothelial cells, having a potential effect on UPIIIb activity and function.